Studies on heterocyclic compounds. II. Syntheses and pharmacologic activities of 1,3,5 triazine derivatives (Japanese)

DOI: 10.1248/yakushi1947.95.5_512

Source and publish data:

Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan p. 512 - 520 (1975)

Update date:2022-08-04

Topics:

Authors:

Tsujikawa

Tsukamura

Takei Takei

Sirakawa

Chiba Chiba

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/yakushi1947.95.5_512

Full text of DOI:10.1248/yakushi1947.95.5_512

NII-Electronic Library Service

Products guided by the article

Product name:4-methoxy-6-[2-(4-phenyl-piperazin-1-yl)-ethyl]-[1,3,5]triazin-2-ylamine

Cas No:5631-11-8

R&D Labs maybe for 5631-11-8

EGBERT CORPORATION

Contact:+86 18616952870

Address:Area
Chengdu Cogon Bio-tech Co., Ltd.

Contact:86-28-85171192

Address:NO.52.YongFeng Rd. Chengdu,610041,P.R.China.
Shenzhen JYMed Technology Co.,Ltd.

website:http://www.jymedtech.com

Contact:+86-755-26612112

Address:1#8,9/F, Biomedicine innovation Industrial Park, No.14, Jinhui Road, Pingshan Sistrict, Shenzhen, China
Zibo Fuxi'er Chemical Co.,Ltd （Shanxian Fuxi'er Chemical Co.,Ltd）

Contact:+86-533-2091422

Address:Eastern 4 on the 3th Road ,Liangxiang Industrial Park, Zibo city ,Shandong,China
Huangshan Honghui Pharm Technology Co., Ltd.(expird)

website:http://www.honghuichem.com

Contact:18855958372

Address:Qingshan Wan No.1,Nanyuan Kou,SheXian Huangshan City,Anhui Province

Relevant to this article

Doi:10.1039/jr9530000951
(1953)
Discovery of 5-substituted-N-arylpyridazinones as inhibitors of p38 MAP kinase

Doi:10.1016/j.bmcl.2010.03.088
(2010)
Preparation and properties of sterically protected diphosphene and fluorenylidenephosphine bearing the 2,6-di-tert-butyl-4-methoxyphenyl group

Doi:10.1246/cl.2003.430
(2003)
Alkyl substituent effects on reductive elimination reactions in zirconocene alkyl hydride complexes. Manipulation of the alkyl steric environment allows the synthesis of a zirconocene dinitrogen complex

Doi:10.1021/om0302239
(2003)
Doi:10.1021/ja00847a026
(1975)
Novel and potent human and rat β₃-adrenergic receptor agonists containing substituted 3-indolylalkylamines

Doi:10.1016/S0960-894X(03)00073-8
(2003)

Article Doi